IPO Boutique

Hyperion Therapeutics, Inc IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Hyperion Therapeutics, Inc, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Hyperion Therapeutics, IncHPTX - $11.00-$13.00 $10.00 $10.505 million7/26/2012
Leerink, Cowen & Company
Co-Manager(s):
Needham & Co.
Health Care
Filing(s):

Filed 2012-04-13



Hyperion Therapeutics, Inc Quote & Chart - Click for current quote - HPTX

About Hyperion Therapeutics, Inc (adapted from Hyperion Therapeutics, Inc prospectus):
They are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.

This description is adapted from Hyperion HPTX prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Hyperion HPTX "HPTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved